Tariffs, FTSE 100, DAX, CAC 40
Novo Nordisk shares climb 3% on easing compounder competition A box of Ozempic made by Novo Nordisk, at a pharmacy in London on March 8, 2024. Hollie Adams | Reuters Shares of Wegovy maker Novo Nordisk climbed 3% Monday as telehealth platform Hims & Hers is reportedly set to cut 4% of its workforce amid…